Updates from European Renal Association (ERA) Congress 2024 – Outcomes and Clinical Implications of GLP-1 RA in T2DM and CKD
Updates from European Renal Association (ERA) Congress 2024 – Outcomes and Clinical Implications of GLP-1 RA in T2DM and CKD
Live Panel Discussion The use of GLP-1 agonists are revolutionising the care of type 2 diabetes and chronic kidney disease. Join us on Monday, 27 May 2024 from 7:00 pm to 8:00 pm (AEST) as our panel of experts discuss the effects of GLP-1 agonists on renal outcomes. We will be reviewing study results presented at […]